1. Home
  2. MLCI vs FBIO Comparison

MLCI vs FBIO Comparison

Compare MLCI & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLCI

Mount Logan Capital Inc. Common Stock

N/A

Current Price

$8.34

Market Cap

98.0M

Sector

Finance

ML Signal

N/A

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$2.94

Market Cap

88.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLCI
FBIO
Founded
N/A
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.0M
88.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MLCI
FBIO
Price
$8.34
$2.94
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.50
AVG Volume (30 Days)
49.1K
337.7K
Earning Date
01-01-0001
11-14-2025
Dividend Yield
1.44%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$104,823,000.00
$62,303,000.00
Revenue This Year
N/A
$29.71
Revenue Next Year
N/A
$49.34
P/E Ratio
N/A
N/A
Revenue Growth
63.13
N/A
52 Week Low
$6.97
$1.33
52 Week High
$8.75
$4.20

Technical Indicators

Market Signals
Indicator
MLCI
FBIO
Relative Strength Index (RSI) N/A 61.41
Support Level N/A $2.49
Resistance Level N/A $3.00
Average True Range (ATR) 0.00 0.15
MACD 0.00 0.04
Stochastic Oscillator 0.00 95.10

Price Performance

Historical Comparison
MLCI
FBIO

About MLCI Mount Logan Capital Inc. Common Stock

Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The Company's reporting segments include asset management and insurance. The asset management segment reflects the Company's historical operations through its subsidiaries, including ML Management, and the insurance segment represents Ability's operations. The Company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The insurance business is operated by Ability. Ability's insurance business consists of premium revenue from long term care insurance policies.

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: